Safety and efficacy of ketorolac in improving the prognosis of acute type A aortic dissection patients: a protocol of a randomized, double-blinded, and placebo-controlled study

Zhikang Lv,Tuo Pan,Haitao Zhang,Yapeng Wang,Yusanjian Matniyaz,Yuxian Tang,Lichong Lu,Dongjin Wang
DOI: https://doi.org/10.1186/s13063-024-08093-x
IF: 2.728
2024-04-11
Trials
Abstract:Acute type A aortic dissection (aTAAD) is a critical and life-threatening condition. Previous research has demonstrated that the use of ketorolac not only reduces the progression, incidence, and severity of aortic aneurysms in animal models, but also decreases postoperative mortality and complications in patients undergoing open abdominal aortic aneurysm replacement. However, there is a lack of studies investigating the efficacy of ketorolac in treating aTAAD in humans. Therefore, we conducted a study to evaluate the safety and efficacy of ketorolac in patients with aTAAD. Our hypothesis was that ketorolac treatment for aTAAD patients would meet safety indicators and effectively improve patient prognosis.
medicine, research & experimental
What problem does this paper attempt to address?